Literature DB >> 26359430

GVHD and miR: good things in small packages.

Jonathan Serody1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26359430      PMCID： PMC4566807          DOI： 10.1182/blood-2015-07-657114

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  Dicers at RISC; the mechanism of RNAi.

Authors:  Marcel Tijsterman; Ronald H A Plasterk
Journal:  Cell       Date:  2004-04-02       Impact factor: 41.582

2.  Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Whitney S Washel; Nazmim S Bhuiya; Corey S Cutler; Edwin P Alyea; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2010-11-19       Impact factor: 22.113

3.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

4.  MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation.

Authors:  Sophia Chen; Benjamin A H Smith; Joseena Iype; Alessandro Prestipino; Dietmar Pfeifer; Sebastian Grundmann; Annette Schmitt-Graeff; Marco Idzko; Yvonne Beck; Gabriele Prinz; Jürgen Finke; Justus Duyster; Robert Zeiser
Journal:  Blood       Date:  2015-05-13       Impact factor: 22.113

5.  MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.

Authors:  Yongxia Wu; Jessica Heinrichs; David Bastian; Jianing Fu; Hung Nguyen; Steven Schutt; Yuejun Liu; Junfei Jin; Chen Liu; Qi-Jing Li; Changqing Xia; Xue-Zhong Yu
Journal:  Blood       Date:  2015-07-02       Impact factor: 22.113

6.  Mature T cell responses are controlled by microRNA-142.

Authors:  Yaping Sun; Katherine Oravecz-Wilson; Nathan Mathewson; Ying Wang; Richard McEachin; Chen Liu; Tomomi Toubai; Julia Wu; Corinne Rossi; Thomas Braun; Thomas Saunders; Pavan Reddy
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

7.  Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.

Authors:  Bin Xiao; Yu Wang; Wei Li; Megan Baker; Jian Guo; Kelly Corbet; Ephraim L Tsalik; Qi-Jing Li; Scott M Palmer; Christopher W Woods; Zhiguo Li; Nelson J Chao; You-Wen He
Journal:  Blood       Date:  2013-09-16       Impact factor: 22.113

Review 8.  mir-17-92: a polycistronic oncomir with pleiotropic functions.

Authors:  Virginie Olive; Qijing Li; Lin He
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988
  8 in total
  4 in total

1.  MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.

Authors:  Yongxia Wu; Steven Schutt; Katelyn Paz; Mengmeng Zhang; Ryan P Flynn; David Bastian; M Hanief Sofi; Hung Nguyen; Min Dai; Chen Liu; Ying-Jun Chang; Bruce R Blazar; Xue-Zhong Yu
Journal:  Blood       Date:  2018-03-12       Impact factor: 22.113

Review 2.  Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.

Authors:  Rihab Gam; Pranali Shah; Rachel E Crossland; Jean Norden; Anne M Dickinson; Ralf Dressel
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

Review 3.  B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Mateja Kralj Juric; Maxim Shevtsov; Petra Mozes; Justyna Ogonek; Rachel E Crossland; Anne M Dickinson; Hildegard T Greinix; Ernst Holler; Eva M Weissinger; Gabriele Multhoff
Journal:  Front Immunol       Date:  2017-01-16       Impact factor: 7.561

Review 4.  Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.

Authors:  Rachel E Crossland; Francesca Perutelli; Katarzyna Bogunia-Kubik; Nuala Mooney; Nina Milutin Gašperov; Maja Pučić-Baković; Hildegard Greinix; Daniela Weber; Ernst Holler; Dražen Pulanić; Daniel Wolff; Anne M Dickinson; Marit Inngjerdingen; Magdalena Grce
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.